Microarrays and Clinical Investigations

New England Journal of Medicine

Volumn 350, Issue 16, 2004, Pages 1595-1597

  Liu, Edison T ^a   Karuturi, Krishna R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ANALYTIC METHOD; ARTIFACT REDUCTION; BIOTECHNOLOGY; CANCER; CANCER CLASSIFICATION; CLINICAL RESEARCH; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE MUTATION; GENOMICS; HUMAN; PREDICTION; PREDICTION ANALYSIS OF MICROARRAY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNIFICANCE ANALYSIS OF MICROARRAY; STANDARD; TECHNIQUE;

CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, MYELOID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 4444238723     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp048050     Document Type: Review

References (3)

1. Miller LD, Long PM, Wong L, Mukherjee S, McShane LM, Liu ET. Optimal gene expression analysis by microarrays. Cancer Cell 2002;2:353-61.
2. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133-43.
3. Simon R. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br J Cancer 2003;89:1599-604.